Dear Colleagues,

I would like to welcome you to this special publication on the most proven balloon expandable covered stent we have at our reach today.

I have been using Getinge’s Advanta V12 balloon expandable covered stent from the very beginning, and I quickly became comfortable and satisfied with its performance.

For more than 15 years, Advanta V12 has paved the road for covered stents, setting the benchmark in terms of patency, predictability, and quality.

The clinical supplement that you have in your hands is a compilation of important publications that evidences the unmatched efforts of Getinge to consistently record Advanta V12 as the most trusted, reliable, and proven balloon expandable covered stent on the market today.

The facts don’t lie. Advanta V12 has touched > 500,000 lives. It is the only balloon expandable covered stent with long-term real-world data,1 has the greatest number of TransAtlantic Inter-Society Consensus D lesions treated in trials,1 and is the only device with a primary patency rate of 74.7% at 5 years.1

Getinge’s balloon expandable covered stent has certainly earned its place in history. Its landmark study, COBEST, has become the reference for all newcomers, and I personally look forward to continuing to use Advanta V12 and its portfolio additions in my practice.

I hope you enjoy this reading.

1. Mwipatayi BP, Ouriel K, Anwari T, et al. A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease. J Vasc Surg. 2020;72:1473-1486.e2. doi: 10.1016/j.jvs.2020.01.084

Eric L.G. Verhoeven, MD, PhD
Chief, Department of Vascular and Endovascular Surgery
General Hospital Nuremberg
Paracelsus Medical University Nuremberg
Nuremberg, Germany
eric.verhoeven@klinikum-nuernberg.de
Disclosures: Speaker for Cook, Gore, Getinge, Bentley, Siemens; receives research grants and royalties from Cook; receives research grants from Gore.

PN011603 REVAA